Annual Report for Fiscal Year 2017
The table below lists studies that were approved by either the internal NIEHS/NTP protocol approval committee or the internal NIEHS/NTP project review committee, but were not started during FY 2017.
| Protocol Title | Study Scientist |
|---|---|
| Prenatal Toxicity Study of 2-{[1-(4-Phenoxyphenoxy)propan-2-yl]oxy}pyridine in New Zealand White Rabbits Exposed Via Gavage | Vicki Sutherland/ Barry McIntyre |
| Toxicokinetic Studies (K03014) of α-Pinene (CAS 80-56-8, Test Article M030014) in Hsd:Sprague Dawley SD Rats and B6C3F1/N Mice Exposed Via Whole Body Inhalation | Cynthia Rider |
| Investigative Mammary and Reproductive Endpoint Studies of α-Pinene in Hsd:Sprague Dawley SD Rats Exposed Via Whole Body Inhalation | Cynthia Rider |
| Modified One-Generation (MOG) Dose Range-Finding Study (MOG00056) of Microcystin LR (CAS# 101043-37-2, M000056) in CD1 Mice Exposed Via Oral Gavage | Vicki Sutherland/ Barry McIntyre |
| Developmental Immunotoxicity Evaluation (# I10482B) of N-Butylbenzenesulfonamide (NBBS, CAS #3622-84-2, Test Article #10057) in Sprague Dawley (HSD: Harlan Sprague Dawley SD) Rats Exposed Via Dosed Feed | Kelly Shipkowski/ Cynthia Rider |
| Modified One-generationStudy (MOG 16001B) of Echinacea Purpurea Root Extract (CAS #90028-20-9,Test Article #16001) in Sprague Dawley (Hsd:Harlan Sprague Dawley SD) Rats Exposed via Gavage | Kristen Ryan |
